Overview
This applied clinical medicine and public health text introduces the fundamental concepts in epidemiological investigation and demonstrates how to integrate emerging research on epigenomics into practice. Epidemiology has a vital strategic role in facilitating and leading evidence discovery in all aspects of human health, with the intent of improving patient and public health through disease control and health promotion practices. It emphasizes what we now know about the transformation the human body and the ecosystem undergo as a result of social structure, environment, daily challenges and mutation. The first part of this text explores the origin of epidemiology, its relationship with medicine and public health, and its role in assessing disease distribution as occurrence or frequency, risk factors, treatment and management. The main direction of this text is to explore the assessment of how gene and environment interactions, termed epigenomic modulations, aberrantly predispose to morbidity, prognosis, survival and mortality at the individual as well as the specific population level. This text presents a novel approach based mainly on epigenomic modulations in the application of epidemiologic investigation in disease incidence, morbidity and mortality at a specific population level for graduate education in public health and clinical sciences as well as medical education.
Full Product Details
Author: Laurens Holmes, Jr. (Nemours Healthcare System, Wilmington, Delaware, USA)
Publisher: Taylor & Francis Ltd
Imprint: Routledge
Weight: 0.648kg
ISBN: 9780367556426
ISBN 10: 0367556421
Pages: 314
Publication Date: 01 December 2023
Audience:
College/higher education
,
Professional and scholarly
,
Tertiary & Higher Education
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Author Information
Laurens Holmes, Jr. is a specialist in Immunology and Infectious Disease as well as an expert in cancer epidemiology and biostatistical modeling. He is a major proponent of aberrant epigenomic modulations in disease incidence, morbidity, prognosis, mortality and survival; and a former Head of the Epidemiology Laboratory at the Nemours Center for Childhood Cancer Research, Wilmington; former clinical and translational science education and training director, Medical College of Wisconsin, Milwaukee; as well as a former Professor of Molecular Epidemiology and Clinical Trials at the University of Delaware, USA. Professor Holmes is currently the Director of the Graduate Public Health Program at Delaware State University, Dover, USA.
